What is Sarda Proteins Ltd (519242) share price return in the past 10 years?

Sarda Proteins Ltd share price has appreciated 35.4% annually (CAGR) over the past ten years.

What is the share price of Sarda Proteins Ltd (519242)?

Company share prices are keep on changing according to the market conditions. The current trading price of Sarda Proteins Ltd (519242) on 08-Jun-2026 16:59:59 at 16:59 is 93.13.

What is the P/E ratio of Sarda Proteins?

The latest standalone P/E ratio of Sarda Proteins as of 08-Jun-2026 is 131.02.

What is the P/B ratio of Sarda Proteins Ltd (519242)?

The latest standalone P/B ratio of Sarda Proteins Ltd (519242) as of 08-Jun-2026 is 8.81.

What is the 52-week high and low of Sarda Proteins Ltd (519242)?

The 52-week high of Sarda Proteins Ltd (519242) is Rs. 144.30 and the 52-week low is Rs. 59.95.

Sarda Proteins Ltd (519242) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Sarda Proteins Ltd (519242)
Brand: Sarda Proteins

Sarda Proteins Ltd (519242)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519242 NSE: Trading | Small Cap | Sarda Proteins Share Price

Sarda Proteins Ltd (519242)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519242 NSE: Trading | Small Cap | Sarda Proteins Share Price

Key Metrics

Valuation Multiples

Market Cap

₹84 Cr.

Current Price

₹93.1

52-Week Low / High

₹60 / 144

TTM EPS

₹0.7

TTM Sales

₹16.2 Cr.

Book Value per Share

₹10.6

P/E Ratio

131.02

Industry PE

35.6

Price to Book (P/B)

8.81

Higher than its 5-year historical median

Price to Sales (P/S)

5.17

Higher than its 5-year historical median

EV/EBITDA

119.31

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

0.32%

Underperforms industry median

Return on Capital Employed (ROCE)

0.86%

Underperforms industry median

Return on Assets (ROA)

0.21%

Operating Profit Margin

0.1%

Net Profit Margin

0.02%

Gross Profit Margin

0.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

1760.77%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

-50%

Asset Quality

Promoter Holding

0.00%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹1 Cr.

Equity

₹9 Cr.

Face Value

₹10

All Time Low / High

₹4.40 / 330.70

Sarda Proteins stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Sarda Proteins Ltd a good quality company?

Sarda Proteins Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Sarda Proteins Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Sarda Proteins Ltd vs industry peers?

Sarda Proteins Ltd revenue CAGR is 34.97%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Sarda Proteins Ltd?

Promoters hold 0.00% of the Sarda Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Sarda Proteins Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 34.7% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-4.5%	-6%	-14.9%	-3.9%	8.4%	3%	15.8%	0.6%	0.8%	0.9%	-
Value Creation Index ⓘ	-1.3	-1.4	-2.1	-1.3	-0.4	-0.8	0.1	-1.0	-0.9	-0.9	-
Growth Parameters ⓘ
Sales ⓘ	2.1	6.2	5.7	7.2	5.4	11.4	10.8	5.8	1.3	24.2	16
Sales YoY Gr.	-	200%	-8.6%	27.8%	-25.2%	110.4%	-5.3%	-46.1%	-77.6%	1,760.8%	-
Adj EPS ⓘ	-0.7	-0.8	-1.8	-0.8	0.2	-0.1	1.8	-0.2	0.1	0	0.7
YoY Gr.	-	NA	NA	NA	NA	-163.2%	NA	-110.6%	NA	-72.7%	-
BVPS (₹) ⓘ	10.9	10.1	8.2	7.5	7.7	7.5	9.3	9.1	9.2	9.3	10.6
Adj Net Profit ⓘ	-0.1	-0.1	-0.3	-0.1	0	-0	0.3	-0	0	0	1
Cash Flow from Ops. ⓘ	-1.2	-0.1	0.5	-0.6	-0.1	-0.1	0.1	-0.3	-0.2	-0.1	-
Debt/CF from Ops. ⓘ	-0.5	-2.1	0	-0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	31.5%	35%	31%	1760.8%
Adj EPS ⓘ	NA	-30.9%	-74.4%	-72.7%
BVPSⓘ	-1.7%	3.9%	-0.2%	0.3%
Share Price	35.4%	22.6%	23.9%	-32.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-4.4	-5.1	-13.1	-6.8	1.6	-1	13.9	-1.4	0.8	0.2	7.2
Op. Profit Mgn % ⓘ	-3.6	-2.7	-5.7	-1.4	1.8	-0.2	2.5	-2.5	-11.3	0.1	1.8
Net Profit Mgn % ⓘ	-5.8	-2.1	-5.5	-2	0.6	-0.2	2.9	-0.6	1.5	0	4
Debt to Equity ⓘ	0.2	0.1	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	390	148	113	76	116	56	63	127	601	35	2,994
Cash Conv. Cycle ⓘ	195	97	91	47	53	26	17	7	0	-2	100

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2.06	6.18	5.65	7.22	5.40	11.36	10.76	5.80	1.30	24.19
Operating Expenses ⓘ +	2.19	6.34	6.01	7.32	5.30	11.38	10.49	5.94	1.44	24.17
Manufacturing Costs	0.07	0.18	0.33	0.01	0	0	0	0	0	0
Material Costs	1.73	5.78	5.16	7.02	5.13	10.98	10.29	5.72	1.21	23.91
Employee Cost	0.11	0.10	0.12	0.12	0.09	0.12	0.13	0.13	0.15	0.07
Other Costs ⓘ	0.27	0.28	0.39	0.18	0.08	0.28	0.08	0.09	0.09	0.19
Operating Profit ⓘ	-0.12	-0.16	-0.35	-0.10	0.10	-0.02	0.27	-0.15	-0.15	0.02
Operating Profit Margin (%)	-6.0%	-2.7%	-6.3%	-1.4%	1.8%	-0.2%	2.5%	-2.5%	-11.3%	0.1%
Other Income ⓘ +	0	0	0	0.03	0.08	0.08	0.09	0.16	0.17	0
Exceptional Items ⓘ	0	0	0	0	0	0	-0	0	0	0
Interest ⓘ	0.03	0.01	0	0	0	0	0	0	0	0
Depreciation ⓘ	0.02	0.01	0.01	0.01	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.17	-0.19	-0.37	-0.09	0.17	0.06	0.35	0.01	0.02	0.02
Tax ⓘ	-0.01	-0.06	-0.04	0.04	0.14	0.08	0.05	0.05	-0	0.02
Profit After Tax	-0.15	-0.13	-0.33	-0.12	0.03	-0.02	0.31	-0.03	0.02	0.01
PAT Margin (%)	-7.5%	-2.1%	-5.9%	-1.7%	0.6%	-0.2%	2.9%	-0.6%	1.5%	0.0%
Adjusted EPS (₹)	-0.9	-0.8	-1.9	-0.7	0.2	-0.1	1.8	-0.2	0.1	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Sarda Proteins - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	2.65	2.52	2.19	2.07	2.10	2.08	2.39	2.35	2.37	2.38
Share Capital ⓘ	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50	2.50
Reserves ⓘ	0.15	0.02	-0.31	-0.44	-0.41	-0.43	-0.12	-0.15	-0.13	-0.13
Debt +	0.60	0.20	0	0.01	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0.60	0.20	0	0.01	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0.01	0	0	0	0	0	0	0	0.22
Others Liabilities ⓘ	-0.14	-0.21	-0.31	-0.29	-0.25	-0.17	-0.11	-0.08	-0.07	-0.07
Total Liabilities ⓘ	3.11	2.51	1.88	1.79	1.85	1.91	2.27	2.27	2.30	2.53
Fixed Assets
Net Fixed Assets ⓘ +	0.06	0.05	0.03	0.02	0.01	0.01	0	0	0	0
Gross Block	0.25	0.25	0.23	0.23	0.09	0.09	0	0	0	0
Accumulated Depreciation	0.19	0.20	0.20	0.21	0.09	0.09	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0.01	0.01	0.01	0	0	0	0	0	0	0
Inventories	1.59	1.05	0.43	0	0	0	0	0	0	0
Trade Receivables	0	0.66	0.69	0.72	0.83	0.77	0.21	0	0	0
Cash Equivalents	0.25	0.24	0.54	0.07	0.10	0.13	0.33	0.18	0.12	0.03
Others Assets ⓘ	1.20	0.50	0.18	0.98	0.91	1	1.74	2.08	2.18	2.49
Total Assets ⓘ	3.11	2.51	1.88	1.79	1.85	1.91	2.27	2.27	2.30	2.53

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-1.20	-0.09	0.48	-0.59	-0.05	-0.05	0.10	-0.30	-0.23	-0.11
PBT ⓘ	-0.17	-0.19	-0.37	-0.09	0.17	0.06	0.35	0.01	0.02	0.02
Adjustment ⓘ	-0.06	0.03	0.01	-0.09	-0.07	-0.08	-0.08	-0.16	-0.16	-0
Changes in Working Capital ⓘ	-0.97	0.07	0.83	-0.41	-0.12	-0.02	-0.17	-0.15	-0.09	-0.13
Tax Paid ⓘ	0	0	0.01	0	-0.03	-0.01	0	0	0	0
Cash Flow From Investing Activity ⓘ +	0.20	-0	0.02	0.11	0.09	0.08	0.09	0.16	0.17	0
Capex	0.02	-0	-0	0	0.01	0	0	0	0	0
Net Investments	0	0	0	0.01	0	0	0	0	0	0
Others ⓘ	0.18	0	0.02	0.10	0.08	0.08	0.09	0.16	0.16	0
Cash Flow From Financing Activity ⓘ +	0.37	-0.42	-0.20	0.01	-0.01	-0	-0	0	-0	0.03
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.01	0	0	0	0	0	0	0	0	0.03
Interest Paid ⓘ	-0.03	-0.01	-0	-0	-0	-0	-0	0	-0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.41	-0.40	-0.20	0.01	-0.01	0	0	0	0	0
Net Cash Flow ⓘ	-0.63	-0.51	0.30	-0.47	0.03	0.03	0.19	-0.14	-0.07	-0.08

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-6.67	-7.31	-20.98	-9.15	2.52	-1.55	21.15	-2.08	1.23	0.32
ROCE (%)	-4.5	-5.96	-14.89	-3.92	8.38	3	15.81	0.55	0.8	0.86
Asset Turnover Ratio	0.7	2.2	2.57	3.94	2.97	6.04	5.15	2.55	0.57	10.02
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	-1.67	N/A	0.32	N/A	-11.5	-11
Working Capital Days
Receivable Days	0	39.20	43.80	35.70	52.50	25.80	16.60	0	0	0
Inventory Days	178.80	77.90	47.70	0	0	0	0	0	0	0
Payable Days	1	0.20	0.20	0	0	0	0	0	0	3.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sarda Proteins Ltd FAQs

The current trading price of Sarda Proteins on 08-Jun-2026 16:59 is ₹93.13.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-Jun-2026 the market cap of Sarda Proteins stood at ₹83.59 Cr

The latest P/E ratio of Sarda Proteins as of 07-Jun-2026 is 131.0.

The latest P/B ratio of Sarda Proteins as of 07-Jun-2026 is 8.81.

The 52-week high of Sarda Proteins is ₹144.3 and the 52-week low is ₹59.95.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sarda Proteins is ₹16.16 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sarda Proteins Ltd is a below average quality company.

The key valuation ratios of Sarda Proteins Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sarda Proteins Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Sarda Proteins Ltd

Sarda Proteins was incorporated in 1991 for manufacturing and marketing of mustard oil. The company is based at Alwar in Rajasthan.

The company received certificate of commencement of Business on December 17, 1991. Later the company had acquired 18000 square metres in the industrial estate of Bhiwadi in Alwar district Rajasthan and started civil work on the same.

The company is having some associate companies namely, Sarda Agro Products, Sarda Oil Industries, Sarda Industrial Corporation, and Aura Infracons.

In the year 2008, company appointed Siddharth Sarda as whole time director of the Company for a period of 5 years with effect from August 01, 2008.

Companyâ€™s registered office is located at E-172 (A) Matsya Industrial Area, Alwar, Rajasthan - 301030

Sarda Proteins Ltd (519242)

Sarda Proteins Ltd (519242)

Sarda Proteins stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Sarda Proteins - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sarda Proteins Ltd FAQs

About Sarda Proteins Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sarda Proteins Ltd (519242)

Sarda Proteins Ltd (519242)

Sarda Proteins stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Sarda Proteins - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sarda Proteins Ltd FAQs

What is the share price of Sarda Proteins?

What is the market cap of Sarda Proteins?

What is the P/E ratio of Sarda Proteins?

What is the P/B ratio of Sarda Proteins?

What is the 52-week high and low of Sarda Proteins?

What is the TTM revenue of Sarda Proteins?

Is Sarda Proteins Ltd a good quality company?

Is Sarda Proteins Ltd undervalued or overvalued?

Is Sarda Proteins Ltd a good buy now?

About Sarda Proteins Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.